Deferasirox | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Deferasirox
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

Zhejiang Hengkang Deferasirox

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Deferasirox

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

73 API Suppliers, 24 USDMF, 11 CEP/COS, 1 JDMF, 24 EU WC, 16 KDMF, 19 NDC API, 52 Listed Suppliers, $ API Reference Price

73 API Suppliers
24 USDMF
11 CEP/COS
1 JDMF
24 EU WC
16 KDMF
19 NDC API
52 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

31 Intermediate Suppliers

31 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

378 FDF Dossiers, 108 FDA Orange Book, 46 Europe, 33 Canada, 144 Australia, 5 South Africa, 42 Listed Dossiers

378 FDF Dossiers
108 FDA Orange Book
46 Europe
33 Canada
144 Australia
5 South Africa
42 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

GRANULE;ORAL - 180MG, GRANULE;ORAL - 360MG, GRANULE;ORAL - 90MG

GRANULE;ORAL - 180MG
GRANULE;ORAL - 360MG
GRANULE;ORAL - 90MG

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 DKSH, 3 Faran Shimi Pharmaceutical, 3 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 4 DFE Pharma, 4 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 17 Kerry, 9 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 7 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 9 Sigachi Industries, 1 Ulanqab Kema New Material, 2 Vasa Pharmachem

1 SPI Pharma
1 DKSH
3 Faran Shimi Pharmaceutical
3 Boai NKY Pharmaceuticals Ltd
3 Gangwal Healthcare
2 Nanjing Well Pharmaceutical
3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
6 BASF
4 DFE Pharma
4 Gangwal Chemicals
1 Ideal Cures Pvt Ltd
17 Kerry
9 Microlex e.U
1 Nanjing Bold Chemical
1 Pharmatrans-Sanaq
3 Pluviaendo
2 Prachin Chemical
7 Roquette
3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shanghai Welltone Material Technology Co., Ltd
9 Sigachi Industries
1 Ulanqab Kema New Material
2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

39 Fillers, Diluents & Binders, 13 Lubricants & Glidants, 13 Direct Compression, 12 Granulation, 11 Thickeners and Stabilizers, 9 Co-Processed Excipients, 4 Coating Systems & Additives, 4 Disintegrants & Superdisintegrants, 4 Taste Masking, 4 Emulsifying Agents, 4 Controlled & Modified Release, 2 Chewable & Orodispersible Aids, 2 Parenteral, 2 Film Formers & Plasticizers, 2 API Stability Enhancers, 2 Solubilizers, 2 Topical, 1 Surfactant & Foaming Agents, 1 Rheology Modifiers

39 Fillers, Diluents & Binders
13 Lubricants & Glidants
13 Direct Compression
12 Granulation
11 Thickeners and Stabilizers
9 Co-Processed Excipients
4 Coating Systems & Additives
4 Disintegrants & Superdisintegrants
4 Taste Masking
4 Emulsifying Agents
4 Controlled & Modified Release
2 Chewable & Orodispersible Aids
2 Parenteral
2 Film Formers & Plasticizers
2 API Stability Enhancers
2 Solubilizers
2 Topical
1 Surfactant & Foaming Agents
1 Rheology Modifiers

DIGITAL CONTENT

59 NEWS #PharmaBuzz

59 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 42 Finished Drug Prices, 9 Annual Reports

3 US Medicaid Prescriptions
42 Finished Drug Prices
9 Annual Reports

MARKET PLACE

10 APIs, 3 FDF Dossiers

10 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 US Patents, 6 Health Canada Patents

3 US Patents
6 Health Canada Patents

REF. STANDARDS & IMPURITIES

16 Others

16 Others

$ API Ref.Price (USD/KG) : 401 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

3 All

01 3NOVARTIS PHARMS CORP

filter Patent Number Reset all filters

3 All

01 39283209

filter API Patent Reset all filters

3 All

01 3Y

filter FDF Patent Reset all filters

3 All

01 3Y

filter Expiration Date Reset all filters

3 All

01 32034-11-21

Synnat Deferasirox

Product Main Page

01

NOVARTIS PHARMS CORP

BioAsia

Not Confirmed

NOVARTIS PHARMS CORP

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-11-21

DEFERASIROX

US Patent Number : 9283209

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206910

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-11-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

NOVARTIS PHARMS CORP

BioAsia

Not Confirmed

NOVARTIS PHARMS CORP

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-11-21

DEFERASIROX

US Patent Number : 9283209

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206910

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-11-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

NOVARTIS PHARMS CORP

BioAsia

Not Confirmed

NOVARTIS PHARMS CORP

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-11-21

DEFERASIROX

US Patent Number : 9283209

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206910

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-11-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!